- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Our Neuroscience Institute's developmental pediatrics research team conducts innovative research that focuses on autism spectrum disorders, sex chromosome aneuploidy and fragile X syndrome.
As a University Center of Excellence in Developmental Disabilities (UCEDD) and Leadership Education in Neurodevelopmental and Related Disabilities, our developmental pediatrics research and its JFK Partners program are dedicated to advancing research for individuals with developmental disabilities and their families.
As part of the eXtraordinarY Babies Study, your child can help researchers identify early predictors of developmental and health outcomes associated with sex chromosome variations.
We're involved with a variety of studies to support children with developmental pediatric conditions. Below are a few of our current studies:
"When we first launched, the eXtraordinarY Kids Clinic was the only clinic of its kind in the country."
Nicole Tartaglia, MD
Founder and Director of the eXtraordinarY Kids ClinicLearn about Dr. Tartaglia's research
We have a robust developmental pediatrics research portfolio supported by a variety of funders in several areas, including autism spectrum disorders, sex chromosome aneuploidy, fragile X syndrome and developmental disabilities. We are the site lead for Colorado for the Developmental Behavioral Pediatrics Research Network.
JFK Partners is a fully integrated program within our Developmental Pediatrics department that is focused on training, leadership, collaboration and clinical excellence. We participate in descriptive, epidemiological, clinical and health services research, which contributes to the knowledge base regarding the health and well-being and education of persons with developmental disabilities and their families.
We are the clinical site in Colorado for the SPARK autism project. SPARK is an online research partnership involving 50,000 individuals with autism and their families. By building a national cohort of 50,000 individuals with autism and their families, SPARK will be the largest autism genetic research cohort in the U.S. The goal of this study is to advance research and understanding of autism.
We are also a member of the National Fragile X Foundation's Fragile X Clinical and Research Consortium.
Our research team is dedicated to improving health and quality of life for children with developmental disabilities and their families, especially those with autism spectrum disorders, developmental disabilities, sex chromosome aneuploidy and fragile X syndrome.
Learn more about the Neuroscience Institute.